{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:21:56Z","timestamp":1793154116920,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejmech.2024.116122","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T15:31:14Z","timestamp":1704295874000},"page":"116122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["N-(Heteroaryl)thiophene sulfonamides as angiotensin AT2 receptor ligands"],"prefix":"10.1016","volume":"265","author":[{"given":"Johan","family":"Wannberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Gising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Henriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc Duy","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"S\u00e4vmarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Sallander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Guti\u00e9rrez-de-Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanin","family":"Ablahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iresha","family":"Spizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey A.","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Widdop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfhild","family":"Gr\u00f6nbladh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia N.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Backlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Hallberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6258-0635","authenticated-orcid":false,"given":"Mats","family":"Larhed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116122_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.191908","article-title":"Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents","volume":"4288","author":"Ondetti","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116122_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/jm00136a001","article-title":"Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension","volume":"24","author":"Ondetti","year":"1981","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.hjh.0000202812.72341.99","article-title":"Renin inhibition with aliskiren: where are we now, and where are we going?","volume":"24","author":"Azizi","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejmech.2024.116122_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1021\/jm9504722","article-title":"Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy","volume":"39","author":"Wexler","year":"1996","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116122_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2012.33","article-title":"Key advances in antihypertensive treatment","volume":"95","author":"Paulis","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2024.116122_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/med.21323","article-title":"Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors","volume":"35","author":"Hallberg","year":"2015","journal-title":"Med. Res. Rev."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116122_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrcardio.2010.85","article-title":"Novel therapeutic targets for hypertension","volume":"78","author":"Paulis","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2024.116122_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157340212800504990","article-title":"AT2 receptor agonists: exploiting the beneficial arm of Ang II signaling","volume":"8","author":"Gallo-Payet","year":"2012","journal-title":"Curr. Hypertens. Rev."},{"key":"10.1016\/j.ejmech.2024.116122_bib9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/pharmrev.120.000281","article-title":"The angiotensin AT2 receptor: from a binding site to a novel therapeutic target","volume":"74","author":"Steckelings","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2024.116122_bib10","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.3390\/cells11213336","article-title":"Angiotensin II-induced signal transduction mechanisms for cardiac hypertrophy","volume":"11","author":"Bhullar","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2024.116122_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2024.116122_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.35.1.155","article-title":"Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function","volume":"35","author":"Carey","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ejmech.2024.116122_bib13","first-page":"67","volume":"vol. 11","author":"Steckelings","year":"2009"},{"key":"10.1016\/j.ejmech.2024.116122_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.coph.2015.01.004","article-title":"Angiotensin type 2 receptors: blood pressure regulation and end organ damage","volume":"21","author":"Sumners","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116122_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.hco.0000166596.44711.b4","article-title":"Angiotensin type-2 receptors and cardiovascular function: are angiotensin type-2 receptors protective?","volume":"20","author":"Carey","year":"2005","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ejmech.2024.116122_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-328X(98)00079-5","article-title":"Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves","volume":"57","author":"Gallinat","year":"1998","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.ejmech.2024.116122_bib17","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1073\/pnas.92.23.10663","article-title":"The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer","volume":"92","author":"Nakajima","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.116122_bib18","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/stem.171","article-title":"Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance","volume":"27","author":"Altarche-Xifr\u00f3","year":"2009","journal-title":"Stem Cell."},{"key":"10.1016\/j.ejmech.2024.116122_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9440(10)64571-3","article-title":"Expression of angiotensin AT1 and AT2 receptors in adult rat cardiomyocytes after myocardial infarction: a single-cell reverse transcriptase-polymerase chain reaction study","volume":"157","author":"Busche","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2024.116122_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI117675","article-title":"Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction","volume":"95","author":"Nio","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2024.116122_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.04-2960fje","article-title":"Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury","volume":"19","author":"Li","year":"2005","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2024.116122_bib22","first-page":"1","volume":"vol. 11","author":"Horiuchi","year":"2009"},{"key":"10.1016\/j.ejmech.2024.116122_bib23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/1389203718666170203150344","article-title":"Angiotensin peptides as AT2 receptor agonists","volume":"18","author":"Hallberg","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ejmech.2024.116122_bib24","first-page":"69","article-title":"Nonpeptide AT2 receptor agonists","volume":"51","author":"Larhed","year":"2016","journal-title":"Med. Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.116122_bib25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/med.21449","article-title":"Small-molecule AT2 receptor agonists","volume":"38","author":"Hallberg","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.116122_bib26","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/acs.jmedchem.9b01780","article-title":"The other angiotensin II receptor: AT2R as a therapeutic target","volume":"63","author":"Juillerat-Jeanneret","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib27","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm049715t","article-title":"Design, synthesis, and biological evaluation, of the first selective nonpeptide AT2 receptor agonist","volume":"47","author":"Wan","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116790","article-title":"Angiotensin II AT2 receptor ligands with phenylthiazole scaffolds","volume":"65","author":"Gopalan","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116804","article-title":"2-Alkyl substituted benzimidazoles as a new class of selective AT2 receptor ligands","volume":"66","author":"Roy","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib30","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1016\/j.bmc.2007.07.026","article-title":"Selective angiotensin II AT2 receptor agonists devoid of the imidazole ring system","volume":"15","author":"Murugaiah","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib31","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1021\/jm2015099","article-title":"From the first selective non-peptide AT2 receptor agonist to structurally related antagonists","volume":"55","author":"Murugaiah","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2012.11.032","article-title":"Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT2) receptor. Effects on neurite outgrowth in NG108-15 cells","volume":"699","author":"Guimond","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116122_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172855","article-title":"Direct stimulation of angiotensin II type 2 receptor reduces nitric oxide production in lipopolysaccharide treated mouse macrophages","volume":"868","author":"Isaksson","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116122_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115859","article-title":"N-(Methyloxycarbonyl)thiophene sulfonamides as high affinity AT2 receptor ligands","volume":"29","author":"Wannberg","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib35","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(13)62337-5","article-title":"EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial","volume":"383","author":"Rice","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116122_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1517\/14728222.2014.957673","article-title":"Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain","volume":"19","author":"Smith Mt","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2024.116122_bib37","article-title":"Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies","volume":"157","author":"Smith","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2024.116122_bib38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2147\/JPR.S128520","article-title":"EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain","volume":"10","author":"Hesselink","year":"2017","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejmech.2024.116122_bib39","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1097\/j.pain.0000000000002252","article-title":"Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy","volume":"162","author":"Rice","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2024.116122_bib40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bmcl.2017.11.042","article-title":"A convenient transesterification method for synthesis of AT2 receptor ligands with improved stability in human liver microsomes","volume":"28","author":"Wannberg","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116122_bib41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/open.201800282","article-title":"A series of analogues to the AT2R prototype antagonist C38 allow fine tuning of the previously reported antagonist binding mode","volume":"8","author":"Isaksson","year":"2019","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.ejmech.2024.116122_bib42","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1039\/c2ob06833h","article-title":"Microwave-Assisted synthesis of small molecules targeting the infectious diseases tuberculosis, HIV\/AIDS, malaria and hepatitis C","volume":"10","author":"Gising","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib43","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1039\/C7CC05383E","article-title":"Directing group assisted copper-mediated aroylation of phenols using 2-bromoacetophenones","volume":"53","author":"Baruah","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.116122_bib44","first-page":"370","article-title":"Subclases of angiotensin II binding sites and their functional significance","volume":"38","author":"Dudley","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116122_bib45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1440-1681.1997.tb01193.x","article-title":"Angiotensin II receptors and renin in the porcine uterus: myometrial AT2 and endometrial AT1 receptors are down-regulated during gestation","volume":"24","author":"Nielsen","year":"1997","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejmech.2024.116122_bib46","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1021\/ml500278g","article-title":"Saralasin and sarile are AT2 receptor agonists","volume":"5","author":"Guimond","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116122_bib47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1476-5381.2009.00575.x","article-title":"Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats","volume":"159","author":"Bosnyak","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116122_bib48","series-title":"Methods Neurosci.","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors","author":"Ballesteros","year":"1995"},{"key":"10.1016\/j.ejmech.2024.116122_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/qsar.200620028","article-title":"Controlled microwave heating as an enabling technology: expedient synthesis of protease inhibitors in perspective","volume":"26","author":"Larhed","year":"2007","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.ejmech.2024.116122_bib50","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance","volume":"47","author":"Brian Houston","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116122_bib51","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2024.116122_bib52","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00204-018-2375-9","article-title":"A simple approach for restoration of differentiation and function in cryopreserved human hepatocytes","volume":"93","author":"\u00d6lander","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116122_bib53","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"29","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2024.116122_bib54","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cell.2015.04.011","article-title":"Structure of the angiotensin receptor revealed by serial femtosecond crystallography","volume":"161","author":"Zhang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116122_bib55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature22035","article-title":"Structural basis for selectivity and diversity in angiotensin II receptors","volume":"544","author":"Zhang","year":"2017","journal-title":"Naturen"},{"key":"10.1016\/j.ejmech.2024.116122_bib56","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib57","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib58","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116122_bib59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/BST20120287","article-title":"Characterization of the dynamic events of GPCRs by automated computational simulations","volume":"41","author":"Guti\u00e9rrez-De-Ter\u00e1n","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2024.116122_bib60","doi-asserted-by":"crossref","first-page":"W455","DOI":"10.1093\/nar\/gkw403","article-title":"A comprehensive web based solution for modeling G-protein coupled receptors","volume":"44","author":"Esguerra","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2024.116122_bib61","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2024.116122_bib62","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2024.116122_bib63","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0006-3495(97)78845-3","article-title":"Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature","volume":"72","author":"Berger","year":"1997","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2024.116122_bib64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature11896","article-title":"Molecular signatures of G-protein-coupled receptors","volume":"494","author":"Venkatakrishnan","year":"2013","journal-title":"Nature"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T14:55:38Z","timestamp":1736866538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":64,"alternative-id":["S0223523424000023"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116122","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-(Heteroaryl)thiophene sulfonamides as angiotensin AT2 receptor ligands","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116122"}}